LIVN Overzicht aandelen
LivaNova PLC, een bedrijf voor medische hulpmiddelen, ontwerpt, ontwikkelt, produceert en verkoopt wereldwijd therapeutische oplossingen. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 3/6 |
| Toekomstige groei | 3/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 5/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
LivaNova PLC Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$52.10 |
| 52 Week Hoogtepunt | US$64.48 |
| 52 Week Laag | US$42.75 |
| Bèta | 1.01 |
| 11 maand verandering | -2.05% |
| 3 maanden verandering | 13.16% |
| 1 Jaar Verandering | 11.40% |
| 33 jaar verandering | -39.47% |
| 5 jaar verandering | -35.48% |
| Verandering sinds IPO | 334.17% |
Recent nieuws en updates
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 12
LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 03LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital
Oct 31Recent updates
We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 12LivaNova PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 03LivaNova (NASDAQ:LIVN) Is Experiencing Growth In Returns On Capital
Oct 31LivaNova: Economics Should Start Making Sustained Improvements
Oct 18Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 31%?
Oct 02LivaNova PLC's (NASDAQ:LIVN) Prospects Need A Boost To Lift Shares
Aug 21LivaNova (NASDAQ:LIVN) Might Have The Makings Of A Multi-Bagger
Jul 30At US$52.79, Is It Time To Put LivaNova PLC (NASDAQ:LIVN) On Your Watch List?
Jul 04Is LivaNova PLC (NASDAQ:LIVN) Trading At A 31% Discount?
Jun 13LivaNova: Focus Is Paying Off
May 12These Return Metrics Don't Make LivaNova (NASDAQ:LIVN) Look Too Strong
Apr 08Is It Time To Consider Buying LivaNova PLC (NASDAQ:LIVN)?
Feb 05A Look At The Intrinsic Value Of LivaNova PLC (NASDAQ:LIVN)
Jan 15LivaNova PLC's (NASDAQ:LIVN) Business And Shares Still Trailing The Industry
Dec 25LivaNova (NASDAQ:LIVN) Could Be At Risk Of Shrinking As A Company
Nov 29We Think LivaNova's (NASDAQ:LIVN) Profit Is Only A Baseline For What They Can Achieve
Nov 08At US$47.94, Is LivaNova PLC (NASDAQ:LIVN) Worth Looking At Closely?
Oct 16Are Investors Undervaluing LivaNova PLC (NASDAQ:LIVN) By 44%?
Sep 25Capital Allocation Trends At LivaNova (NASDAQ:LIVN) Aren't Ideal
Jul 26Should You Investigate LivaNova PLC (NASDAQ:LIVN) At US$51.43?
Jul 03An Intrinsic Calculation For LivaNova PLC (NASDAQ:LIVN) Suggests It's 37% Undervalued
Jun 09Investors Could Be Concerned With LivaNova's (NASDAQ:LIVN) Returns On Capital
Apr 13What Does LivaNova PLC's (NASDAQ:LIVN) Share Price Indicate?
Mar 13Estimating The Fair Value Of LivaNova PLC (NASDAQ:LIVN)
Feb 15Returns At LivaNova (NASDAQ:LIVN) Are On The Way Up
Nov 25Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Oct 29LivaNova Loses Profit Momentum On Higher R&D Expense
Oct 13LivaNova PLC (NASDAQ:LIVN) Shares Could Be 30% Below Their Intrinsic Value Estimate
Oct 11FDA labels recall of blood bypass pump systems by LivaNova as most serious
Sep 30Returns On Capital At LivaNova (NASDAQ:LIVN) Have Hit The Brakes
Aug 09LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
Aug 03Is There Now An Opportunity In LivaNova PLC (NASDAQ:LIVN)?
Jul 19Rendement voor aandeelhouders
| LIVN | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | 0.9% | -1.1% | -2.2% |
| 1Y | 11.4% | 23.0% | 30.1% |
Rendement versus industrie: LIVN presteerde slechter dan de US Medical Equipment -sector, die het afgelopen jaar een rendement van 23 % opleverde.
Rendement versus markt: LIVN presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 30.1 % opleverde.
Prijsvolatiliteit
| LIVN volatility | |
|---|---|
| LIVN Average Weekly Movement | 3.7% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: LIVN heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van LIVN is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2015 | 2,900 | Vladimir Makatsaria | www.livanova.com |
LivaNova PLC, een bedrijf gespecialiseerd in medische apparatuur, ontwerpt, ontwikkelt, produceert en verkoopt wereldwijd therapeutische oplossingen. Het bedrijf is actief in de segmenten Cardiopulmonaire ondersteuning, Neuromodulatie en Geavanceerde circulatieondersteuning. Het segment Cardiopulmonaire ontwikkelt, produceert en verkoopt cardiopulmonale producten, waaronder oxygenators, hart-longmachines, autotransfusiesystemen, perfusieslangsystemen, canules, connectoren en andere gerelateerde producten.
LivaNova PLC Samenvatting
| LIVN fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$2.84b |
| Inkomsten(TTM) | US$23.68m |
| Inkomsten(TTM) | US$1.24b |
119.5x
Koers/Winstverhouding2.3x
P/S-verhoudingIs LIVN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| LIVN resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$1.24b |
| Kosten van inkomsten | US$396.25m |
| Brutowinst | US$845.49m |
| Overige uitgaven | US$821.80m |
| Inkomsten | US$23.68m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 0.44 |
| Brutomarge | 68.09% |
| Nettowinstmarge | 1.91% |
| Schuld/Eigen Vermogen Verhouding | 47.8% |
Hoe presteerde LIVN op de lange termijn?
Bekijk historische prestaties en vergelijking